Bluejay Diagnostics, Inc.
BJDX
$4.00
-$0.03-0.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -100.00% |
| Gross Profit | -- | -- | -- | -- | -100.00% |
| SG&A Expenses | -16.47% | -21.79% | -15.51% | -11.85% | -7.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.22% | -16.56% | -1.16% | 7.78% | 22.29% |
| Operating Income | 22.22% | 16.56% | -1.32% | -10.66% | -25.99% |
| Income Before Tax | 14.43% | 12.10% | 0.82% | -7.06% | -19.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.43% | 12.10% | 0.82% | -7.06% | -19.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.43% | 12.10% | 0.82% | -7.06% | -19.90% |
| EBIT | 22.22% | 16.56% | -1.32% | -10.66% | -25.99% |
| EBITDA | 17.77% | 15.99% | 1.87% | -5.47% | -20.43% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
